Gut microbiome immaturity and childhood acute lymphoblastic leukaemia

Area of Science:

• Pediatric Oncology
• Microbiome Research
• Immunology

Background:

• Acute lymphoblastic leukaemia (ALL) is the most common childhood cancer.
• Emerging evidence suggests a link between gut microbiome development and ALL risk.
• Early-life factors like birth mode and feeding practices are known ALL risk indicators.

Purpose of the Study:

• To investigate the association between gut microbiome maturation and childhood ALL at diagnosis.
• To explore the potential role of microbiome deficits in ALL pathogenesis.
• To identify potential targets for microbiome-based interventions.

Main Methods:

• Comparative analysis of gut microbiome composition in children with ALL versus healthy controls.
• Examination of associations between microbiome features and early-life epidemiological factors.
• Assessment of the functional implications of observed microbiome alterations, particularly short-chain fatty acid production.

Main Results:

• Children with ALL exhibit delayed gut microbiome maturation compared to healthy children.
• A consistent deficiency in short-chain fatty acid-producing bacteria is observed in ALL patients.
• These microbiome alterations may be associated with known ALL risk factors such as C-section birth and reduced breastfeeding.

Conclusions:

• A gut microbiome deficit in early life may contribute to the development of childhood ALL.
• Dysregulated immune responses due to altered gut bacteria could increase ALL risk.
• Microbiome-targeted interventions hold promise for future risk reduction strategies in childhood ALL.